Application 210730

Type: NDA
Sponsor: TREVENA INC

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	OLINVYK	OLICERIDINE	INJECTABLE;INTRAVENOUS	1.5MG	No	No
002	OLINVYK	OLICERIDINE	SOLUTION;INTRAVENOUS	2MG/2ML (1MG/ML)	Yes	Yes
003	OLINVYK	OLICERIDINE	SOLUTION;INTRAVENOUS	30MG/30ML (1MG/ML)	Yes	Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N210730-001	OLINVYK	OLICERIDINE	1MG/ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30
N210730-002	OLINVYK	OLICERIDINE	2MG/2ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30
N210730-003	OLINVYK	OLICERIDINE	30MG/30ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30

Orange Book patents#

Current patent rows page 1 of 1 · 15 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N210730-001	11077098	2032-03-23	U-2986	Drug substance, Drug product	2021-09-01
N210730-001	11931350	2032-03-23	U-2986	Drug substance	2024-04-09
N210730-001	8835488	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20
N210730-001	9309234	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20
N210730-001	9642842	2032-03-23	U-2986	Drug product	2020-11-20
N210730-002	11077098	2032-03-23	U-2986	Drug substance, Drug product	2021-09-01
N210730-002	11931350	2032-03-23	U-2986	Drug substance	2024-04-09
N210730-002	8835488	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20
N210730-002	9309234	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20
N210730-002	9642842	2032-03-23	U-2986	Drug product	2020-11-20
N210730-003	11077098	2032-03-23	U-2986	Drug substance, Drug product	2021-09-01
N210730-003	11931350	2032-03-23	U-2986	Drug substance	2024-04-09
N210730-003	8835488	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20
N210730-003	9309234	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20
N210730-003	9642842	2032-03-23	U-2986	Drug product	2020-11-20

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 114 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N210730-001	OLINVYK	1MG/ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210730-002	OLINVYK	2MG/2ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210730-003	OLINVYK	30MG/30ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N210730-001	OLINVYK	1MG/ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210730-002	OLINVYK	2MG/2ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210730-003	OLINVYK	30MG/30ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N210730-001	OLINVYK	1MG/ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210730-002	OLINVYK	2MG/2ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210730-003	OLINVYK	30MG/30ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210730-001	OLINVYK	1MG/ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210730-002	OLINVYK	2MG/2ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210730-003	OLINVYK	30MG/30ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N210730-001	OLINVYK	1MG/ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210730-002	OLINVYK	2MG/2ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210730-003	OLINVYK	30MG/30ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210730-001	OLINVYK	1MG/ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210730-002	OLINVYK	2MG/2ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210730-003	OLINVYK	30MG/30ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N210730-001	OLINVYK	1MG/ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N210730-002	OLINVYK	2MG/2ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N210730-003	OLINVYK	30MG/30ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N210730-001	OLINVYK	1MG/ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2020-10-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N210730-002	OLINVYK	2MG/2ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2020-10-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N210730-003	OLINVYK	30MG/30ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD	2020-10-30	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N210730-001	OLINVYK	1MG/ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2020-10-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N210730-002	OLINVYK	2MG/2ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2020-10-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N210730-003	OLINVYK	30MG/30ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2020-10-30	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N210730-001	OLINVYK	1MG/ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2020-10-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N210730-002	OLINVYK	2MG/2ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2020-10-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N210730-003	OLINVYK	30MG/30ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2020-10-30	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N210730-001	OLINVYK	1MG/ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2020-10-30	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N210730-002	OLINVYK	2MG/2ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2020-10-30	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N210730-003	OLINVYK	30MG/30ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2020-10-30	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N210730-001	OLINVYK	1MG/ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2020-10-30	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N210730-002	OLINVYK	2MG/2ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2020-10-30	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N210730-003	OLINVYK	30MG/30ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2020-10-30	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N210730-001	OLINVYK	1MG/ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2020-10-30	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N210730-002	OLINVYK	2MG/2ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2020-10-30	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N210730-003	OLINVYK	30MG/30ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2020-10-30	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N210730-001	OLINVYK	1MG/ML (1MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2020-10-30	`301d65b070ca…`

Observed Orange Book patent history#

Patent history page 1 of 13 · 498 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N210730-001	11077098	2032-03-23	U-2986	Drug substance, Drug product	2021-09-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210730-001	11931350	2032-03-23	U-2986	Drug substance	2024-04-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210730-001	8835488	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210730-001	9309234	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210730-001	9642842	2032-03-23	U-2986	Drug product	2020-11-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210730-002	11077098	2032-03-23	U-2986	Drug substance, Drug product	2021-09-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210730-002	11931350	2032-03-23	U-2986	Drug substance	2024-04-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210730-002	8835488	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210730-002	9309234	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210730-002	9642842	2032-03-23	U-2986	Drug product	2020-11-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210730-003	11077098	2032-03-23	U-2986	Drug substance, Drug product	2021-09-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210730-003	11931350	2032-03-23	U-2986	Drug substance	2024-04-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210730-003	8835488	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210730-003	9309234	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210730-003	9642842	2032-03-23	U-2986	Drug product	2020-11-20	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N210730-001	11077098	2032-03-23	U-2986	Drug substance, Drug product	2021-09-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210730-001	11931350	2032-03-23	U-2986	Drug substance	2024-04-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210730-001	8835488	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210730-001	9309234	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210730-001	9642842	2032-03-23	U-2986	Drug product	2020-11-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210730-002	11077098	2032-03-23	U-2986	Drug substance, Drug product	2021-09-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210730-002	11931350	2032-03-23	U-2986	Drug substance	2024-04-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210730-002	8835488	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210730-002	9309234	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210730-002	9642842	2032-03-23	U-2986	Drug product	2020-11-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210730-003	11077098	2032-03-23	U-2986	Drug substance, Drug product	2021-09-01	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210730-003	11931350	2032-03-23	U-2986	Drug substance	2024-04-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210730-003	8835488	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210730-003	9309234	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210730-003	9642842	2032-03-23	U-2986	Drug product	2020-11-20	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N210730-001	11077098	2032-03-23	U-2986	Drug substance, Drug product	2021-09-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210730-001	11931350	2032-03-23	U-2986	Drug substance	2024-04-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210730-001	8835488	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210730-001	9309234	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210730-001	9642842	2032-03-23	U-2986	Drug product	2020-11-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210730-002	11077098	2032-03-23	U-2986	Drug substance, Drug product	2021-09-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210730-002	11931350	2032-03-23	U-2986	Drug substance	2024-04-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210730-002	8835488	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210730-002	9309234	2032-03-23	U-2986	Drug substance, Drug product	2020-11-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210730-002	9642842	2032-03-23	U-2986	Drug product	2020-11-20	`011fe1cb6892…`

Observed Orange Book exclusivity history#

Exclusivity history page 3 of 3 · 99 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N210730-003	NCE	2025-10-30	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N210730-001	NCE	2025-10-30	`053a50430f4f…`
2023-05-13 08:27 UTC	2023-05	N210730-002	NCE	2025-10-30	`053a50430f4f…`
2023-05-13 08:27 UTC	2023-05	N210730-003	NCE	2025-10-30	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N210730-001	NCE	2025-10-30	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N210730-002	NCE	2025-10-30	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N210730-003	NCE	2025-10-30	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N210730-001	NCE	2025-10-30	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N210730-002	NCE	2025-10-30	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N210730-003	NCE	2025-10-30	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N210730-001	NCE	2025-10-30	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N210730-002	NCE	2025-10-30	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N210730-003	NCE	2025-10-30	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N210730-001	NCE	2025-10-30	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N210730-002	NCE	2025-10-30	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N210730-003	NCE	2025-10-30	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N210730-001	NCE	2025-10-30	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N210730-002	NCE	2025-10-30	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N210730-003	NCE	2025-10-30	`cb3db0bc1861…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
OLINVYK	OLICERIDINE	Trevena, Inc.	ce167984-8b9d-40b7-84ce-d0f33fff1eaa	2025-12-31	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 210730 application number: NDA210730 ndc (product): 71308-301 ndc (product): 71308-011 ndc (product): 71308-021

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 12 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
71308-011	OLINVYK	OLICERIDINE	Trevena, Inc.	NDA	Current
71308-011	OLINVYK	OLICERIDINE	Trevena, Inc.	NDA	Current
71308-011	OLINVYK	OLICERIDINE	Trevena, Inc.	NDA	Current
71308-011	OLINVYK	OLICERIDINE	Trevena, Inc.	NDA	Current
71308-021	OLINVYK	OLICERIDINE	Trevena, Inc.	NDA	Current
71308-021	OLINVYK	OLICERIDINE	Trevena, Inc.	NDA	Current
71308-021	OLINVYK	OLICERIDINE	Trevena, Inc.	NDA	Current
71308-021	OLINVYK	OLICERIDINE	Trevena, Inc.	NDA	Current
71308-301	OLINVYK	OLICERIDINE	Trevena, Inc.	NDA	Current
71308-301	OLINVYK	OLICERIDINE	Trevena, Inc.	NDA	Current
71308-301	OLINVYK	OLICERIDINE	Trevena, Inc.	NDA	Current
71308-301	OLINVYK	OLICERIDINE	Trevena, Inc.	NDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
84654	SUPPL	2026-01-06
84540	SUPPL	2025-12-23
77060	SUPPL	2023-12-19
76971	SUPPL	2023-12-18
68935	ORIG	2021-10-08
66545	SUPPL	2021-03-05
66543	SUPPL	2021-03-05
64493	ORIG	2020-09-04
64247	ORIG	2020-08-10
64245	ORIG	2020-08-10